Science & Enterprise subscription

Follow us on Twitter

  • Make me wanna shout ... #BillsMafia https://t.co/iF1vhKHXtu
    about 1 hour ago
  • First of two podcasts with experiences of news photographers in the insurrection. Thanks @cherissmay for sharing yo… https://t.co/aCjPD6ct84
    about 17 hours ago
  • Half or more of American adults express negative opinions about the way Covid-19 vaccines are distributed, accordin… https://t.co/9l2SUpW85u
    about 23 hours ago
  • New post on Science and Enterprise: Infographic – US Public Down on Vaccine Rollout https://t.co/vegz3ihvIO #Science #Business
    about 23 hours ago
  • We've written several times about Lander and his work, including companies he founded. ... Biden to Elevate Science… https://t.co/rWVGTa1gPL
    about 1 day ago

Please share Science & Enterprise

Covid-19 Antibody Developer Raises $483M in IPO

Wall Street sign

A biotechnology company developing therapeutic antibodies for Covid-19 infections is raising $483 million in its initial public offering of common stock. . . . → Read More: Covid-19 Antibody Developer Raises $483M in IPO

Industry, Univ Labs Partner on Cannabinoid Pain Drug

Cannabis plant

A Canadian medical school lab is helping evaluate and develop a pain relief drug made by a company developing therapies from cannabis. . . . → Read More: Industry, Univ Labs Partner on Cannabinoid Pain Drug

Wheat Genome Study IDs Critical Genes, Traits

Curtis Pozniak in wheat field

An international research team identified key features of the complex wheat genome, including genes affecting the grain’s yield, quality, and survival. . . . → Read More: Wheat Genome Study IDs Critical Genes, Traits

Lilly, NIH Halt Covid-19 Antibody Therapy Trial

Stop signs graphic

Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody to treat hospitalized Covid-19 patients. . . . → Read More: Lilly, NIH Halt Covid-19 Antibody Therapy Trial

New Company IDs Drugs Targeting Cancer Cell Networks

Cancer magnified

A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors. . . . → Read More: New Company IDs Drugs Targeting Cancer Cell Networks

Int’l Lab Network to Assess Covid-19 Vaccines

Syringes

Six clinical testing laboratories worldwide plan to evaluate vaccines for protecting against Covid-19 infections with a common set of test protocols. . . . → Read More: Int’l Lab Network to Assess Covid-19 Vaccines

Group Advancing Electronic Spinal Cord Injury Therapies

Spine

A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries. . . . → Read More: Group Advancing Electronic Spinal Cord Injury Therapies

Early Trial Results Show Antibody Treating Covid-19

SARS-Cov-2 virus

First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy at a specific dosage, cleared their SARS-CoV-2 viruses within 11 days. . . . → Read More: Early Trial Results Show Antibody Treating Covid-19

Covid-19 Vaccines, Therapies – 31 August 2020

Covid-19 vaccine and therapy tracker

The European Commission announced today a contribution of €400 million ($US 477 million) to the COVID-19 Vaccine Global Access, or Covax, consortium. . . . → Read More: Covid-19 Vaccines, Therapies – 31 August 2020

Covid-19 Vaccines, Therapies – 17 August 2020

Vaccine and therapy tracker

The number of new Covid-19 therapies increased by eight over the past week to 364, while the number of therapies in clinical trials also jumped by eight. . . . → Read More: Covid-19 Vaccines, Therapies – 17 August 2020